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A B S T R A C T
A human induced pluripotent stem cell (iPSC) line was generated from fibroblasts of a patient with nonketotic hyperglycinemia bearing the biallelic changes
c.1742C > G (p.Pro581Arg) and c.2368C > T (p.Arg790Trp) in the GLDC gene. Reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC were delivered using a
non-integrative method based on the Sendai virus. Once established, iPSCs have shown full pluripotency, differentiation capacity and genetic stability. This cellular
model provides a good resource for disease modeling and drug discovery.
Resource table
Unique stem cell lines
identifier
UAMi005-A
Alternative name of st-
em cell line
GLDC27-FiPS4F-1
Institution Centro de Biología Molecular Severo Ochoa UAM-CSIC,
Universidad Autónoma de Madrid, CIBERER, IDIPaz,
Madrid, Spain.
Contact information of
distributor
Eva Richard, erichard@cbm.csic.es
Type of cell line iPSC
Origin Human
Additional origin info Age: died at 1 month of age
Sex: Male
Ethnicity if known: Caucasian
Cell Source Fibroblasts
Clonality Clonal
Method of reprogram-
ming
Sendai Virus
Genetic modification Yes
Type of modification Hereditary
Associated disease Nonketotic hyperglycinemia
Gene/locus GLDC/9p23-p24
Method of modification Non applicable
Name of transgene or
resistance
Non applicable
Inducible/constitutive
system
Non applicable
Date archived/stock d-
ate
May 2019
Cell line repository/ba-
nk
Spanish National Bank of Cell Lines http://www.isciii.es/
ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-
estructura-directiva/fd-subdireccion-general-
investigacion-terapia-celular-medicina-regenerativa/fd-
centros-unidades/fd-banco-nacional-lineas-celulares/fd-
lineas-celulares-disponibles/lineas-de-celulas-iPS.shtml
Ethical approval Patient informed consent obtained.
Ethics Review Board-competent authority approval ob-
tained (CEI-75-1372)
Resource utility
The establishment of an iPSC line with missense changes in the
GLDC gene of a nonketotic hyperglicinemia patient will allow getting
insights into the pathomechanisms of this genetic disease that provokes
severe neurological alterations, and exploring new therapeutic options.
Resource details
Nonketotic hyperglycinemia (NKH, OMIM # 605899) is a rare ge-
netic defect in glycine metabolism caused by a defective glycine
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cleavage activity primarily due to mutations in the GLDC gene encoding
for the GCS P-protein, one of the three catalytic components of the
mitochondrial multienzymatic complex. The deficiency provokes a
considerable accumulation of glycine in all tissues, especially in central
nervous system, leading a severe neurological phenotype whose pa-
thomechanism is not completely understood, but probably involves an
aberrant neurotransmission and proliferation disturbance. Here, we
accomplish the reprogramming of fibroblasts from a previously de-
scribed NKH-patient (Bravo-Alonso et al., 2017), bearing the GLDC
mutations c.1742C > G (p.Pro581Arg) and c.2368C > T
(p.Arg790Trp) using the CytoTune™ iPS Reprogramming kit delivering
the four human reprogramming factors OCT3/4, SOX2, c-MYC and
KLF4 (Takahashi et al., 2007). The iPSC line GLDC27-FiPS4F-1
(UAMi005-A) (GLDC27–1 in figures for short) exhibited classical em-
bryonic stem cell morphology and growth behaviour on feeder layers
and on feeder-free layers (Fig. 1A, Table 1). Clearance of the vectors
and exogenous reprogramming factor genes was verified with reverse
transcription polymerase chain reaction (RT-PCR) using specific pri-
mers with no virus present at passage 9 (Fig. 1B). Immunofluorescent
staining (Fig. 1C, Table 1) and flow cytometry (Fig. 1D, Table 1)
showed that the iPSCs expressed high levels of pluripotency associated
markers (transcription factors OCT4, NANOG and SOX2, and surface
markers SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81). The three-germ-
layer differentiation capacities of the iPSCs were revealed with an in
vitro assay based on embryoid bodies (EB) formation (Fig. 1E, Table 1).
Mycoplasma testing by PCR revealed a negative result (Supplementary
Fig. S1A). The iPSC line retained the GLDC mutations (Supplementary
Fig. S1B) and normal karyotype (46, XY) after 22 passages in culture
(Supplementary Fig. S1C, Table 1). We also confirmed by DNA finger-
printing analysis that the line was derived from patient-derived fibro-
blasts (Supplementary Fig. S1D, Table 1).
Materials and methods
Non-integrative reprogramming of mutant GLDC fibroblasts into iPSC
The present study included available fibroblasts from a NKH patient
with defects in the GLDC gene, that were reprogrammed using the
CytoTune™ iPS Reprogramming kit (ThermoFisher Scientific) following
the manufacturer's instructions. The study was approved by the
Institutional Ethical Committee (Universidad Autónoma de Madrid).
Experimental methods were performed in accordance with the relevant
guidelines and regulations, and the informed consent was obtained
from the legal care-givers.
Cell culture
iPSCs were maintained and expanded on feeder layers as previously
described (Alonso-Barroso et al., 2017). iPSCs were also adapted and
cultured in feeder-free conditions on Matrigel® (Corning) using
mTESR™1 medium (StemCell™ Technologies). In this case for the iPSC
propagation, ReleSR™ (StemCell™ Technologies) was used when co-
lonies were 70–80% confluent. In some cases, cells were detached with
Accutase™ (StemCell™ Technologies) into a single cell suspension and
resuspended in mTESR™1 medium with 10 μM Rock inhibitor (Stem-
Cell™ Technologies). iPSCs were maintained in a humidified incubator
at 37 °C with 5% CO2.
Detection of Sendai virus genome and transgenes
RT-PCR was performed using total RNA from the transduced cell
pool at passage zero (positive control, C+ in Fig. 1 panel B) and from
the iPSC line at passage 9 as described (Alonso-Barroso et al., 2017).
Primers indicated in Table 2 and manufacturer's instructions were used
to perform the PCR technique. In Fig. 1 panel B: C+: transduced cell
pool at passage zero; C–: non-template control.
Immunofluorescence analysis
iPSC were seeded onto matrigel-coated 15 μ-Slide 8 well culture
plates (Ibidi) and fixed with Formaline Solution 10% (Sigma-Aldrich).
Immunofluorescence analysis was performed as previously described
(Alonso-Barroso et al., 2017) and images were obtained using a con-
focal laser scanning microscope Nikon A1R+. In Fig. 1 scale bars:
100 μm.
Flow cytometry analysis
We analysed the pluripotency-associated markers SSEA-3 and SSEA-
4 by flow cytometry as described (Alonso-Barroso et al., 2017) in a BD
FACSCanto™ A instrument (Becton Dickinson) using FACSDiva 8.0
software. Unstained iPSCs and the corresponding isotype antibodies
were used as negative controls to exclude data from non-specific
fluorescence.
In vitro differentiation
iPSCs were detached with Accutase™ into a single cell suspension
and resuspended in mTESR™1 medium with 10 μM Rock inhibitor. EB
formation was induced by seeding 20,000–30,000 iPS cells in 120 μl of
mTESR™1 medium in each well of 96-well v-bottom, low attachment
plates (Deltalab). The generated EBs were collected on day 5, seeded
onto matrigel-coated 15 μ-Slide 8 well culture plates (Ibidi) and dif-
ferentiated into the three-germ layers for 2–3weeks using the differ-
entiation mediums as described (Alonso-Barroso et al., 2017).
Mycoplasma detection
PCR was used to test mycoplasma contamination (Uphoff and
Drexler, 2014). A positive sample with mycoplasma was used as a
control. In Supplementary Fig. S1A: positive control (C+).
Mutation analysis
Genomic DNA was extracted from patient-derived fibroblasts and
iPSCs using MagNA Pure Compact DNA Isolation kit and MagNA Pure
Compact instrument (Roche) followed by PCR amplification using
FastStart Taq DNA Polymerase (Roche) and the specific primers in-
dicated in Table 2. Amplifications were carried out on Veriti Thermal
Cycler (ThermoFisher Scientific) using the following program: 94 °C
5min; 94 °C 25 s, 55 °C 25 s and 72 °C 40 s for 38 cycles; 72 °C 7min and
4 °C indefinite. Amplified PCR fragments were sequenced in an
ABI3730 sequencer (Applied Biosystems).
Karyotype analysis
Karyotype analysis of the iPSC line was carried out using cells at 22
culture passage which were processed using standard cytogenetic
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Fig. 1.
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Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Fig. 1 panel A
Phenotype Qualitative analysis
(Immunocytochemistry)
Positive for: OCT4, NANOG, SOX2, SSEA-3, TRA-1-81, SSEA-4
and TRA-1-60
Fig. 1 panel C
Quantitative analysis (Flow cytometry) SSEA-3: 99.8%
SSEA-4: 98.4%
Fig. 1 panel D
Genotype Karyotype (G-banding) and resolution 46XY Resolution 450–500 Supplementary Fig. S1 panel
C
Identity STR analysis 16 sites tested and all of them matched Supplementary Fig. S1 panel
D
Mutation analysis (IF
APPLICABLE)
Sequencing c.1742C > G (p.Pro581Arg)
c.2368C > T (p.Arg790Trp)
Supplementary Fig. S1 panel
B
Southern Blot OR WGS Not performed
Microbiology and virology Mycoplasma Mycoplasma testing by PCR: negative Supplementary Fig. S1 panel
A
Differentiation potential Embryoid body formation Expression of α-1-fetoprotein (endoderm), α-smooth muscle
actin (mesoderm) and β-III-tubulin Tuj1 (ectoderm)
Fig. 1 panel E
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C Not performed No
Genotype additional info
(OPTIONAL)
Blood group genotyping Not performed No
HLA tissue typing Not performed No
Table 2
Reagents details.
Antibodies used for immunocytochemistry/flow-cytometry
Antibody Dilution Company Cat # and RRID
Pluripotency markers Mouse IgG anti-OCT4 1:60 Santa Cruz Cat# sc-5279, AB_628051
Rat IgM anti-SSEA-3 1:3 Hybridoma Bank Cat# MC-631, AB_528476
Rabbit IgG anti-SOX2 1:100 Fisher Thermo Scientific Cat# PA1–16968, AB_2195781
Mouse IgG anti-SSEA-4 1:3 Hybridoma Bank Cat# MC-813-70, AB_528477
Mouse IgM anti-TRA-1-60 1:200 Millipore Cat# MAB4360, AB_2119183
Goat IgG anti-NANOG human 1:25 R&D Cat# AF1997, AB_355097
Mouse IgM anti-TRA-1-81 1:200 Millipore Cat# MAB4381, AB_177638
Differentiation markers Rabbit IgG anti-α-Fetoprotein 1:400 Dako Cat# A0008, AB_2650473
Mouse IgG anti-β-III-Tubulin Tuj1 1:500 Covance Cat# MMS-435P, AB_231377
Mouse IgG anti-α-smooth muscle actin 1:400 Sigma-Aldrich Cat# A5228, AB_262054
Secondary antibodies Alexa 555 Donkey anti-Mouse IgG 1:200 Thermo Fischer Cat# A-31570, AB_2536180
Alexa 488 Goat anti-Rat IgM 1:200 Thermo Fischer Cat#A-21212, AB_2535798
Alexa 488 Donkey anti-Rabbit IgG 1:200 Thermo Fischer Cat# A-31572, AB_162543
Alexa 555 Donkey anti-Mouse IgG 1:200 Thermo Fischer Cat# A-31570, AB_2536180
Alexa 647 Goat anti-Mouse IgM 1:200 Thermo Fischer Cat# A-21238, AB_2535807
Alexa 647 Donkey anti-Goat IgG 1:200 Thermo Fischer Cat# A-21447, AB_2535864
Cy3 Donkey anti-Mouse IgM 1:200 Jackson Cat# 715–165-140, AB_2340812
Alexa 647 Goat anti-mouse IgG 1:600 Thermo Fischer Cat# A- 21235, AB_2535804
Primers
Target Forward/Reverse primer (5′-3′)
Reverse transcription-PCR SeV genome (181 pb) GGATCACTAGGTGATATCGAGC/ACCAGACAAGAGTTTAAGAGATATGTATC
KOS transgene (528 bp) ATGCACCGCTACGACGTGAGCGC/ACCTTGACAATCCTGATGTGG
KLF4 transgene (410 bp) TTCCTGCATGCCAGAGGAGCCC/AATGTATCGAAGGTGCTCAA
c-MYC transgene (532 bp) TAACTGACTAGCAGGCTTGTCG/TCCACATACAGTCCTGGATGATGATG
Targeted mutation analysis/sequencing
(PCR)
GLDC-exon 15 (500 bp) TGTCCCACTTTTAAATGAAGACAG/ACACGATGCACCTTCTAGCC
GLDC-exon 20 (373 bp) AAGAACAAGGCTTTCTGGGAG/CATCAGCAATATTCTTTGAACCAC
Mycoplasma detection (PCR) Mycoplasma species (986 bp: internal control band; and
520 bp: mycoplasma specific band)
Forward primers:
CGCCTGAGTACGTTCGC
CGCCTGAGTACGTACGC
TGCCTGGGTAGTACATTCGC
TGCCTGAGTAGTACATTCGC
CGCCTGAGTAGTATGCTCGC
CACCTGAGTAGTATGCTCGC
CGCCTGGGTAGTACATTCGC
Reverse primers:
GCGGTGTGTACAAGACCCGA
GCGGTGTGTACAAAACCCGA
GCGGTGTGTACAAACCCCGA
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techniques as described (Alonso-Barroso et al., 2017). At least 20 me-
taphases were karyotyped.
DNA fingerprinting analysis
DNA fingerprinting analysis was performed as previously described
at Parque Científico de Madrid, Campus Moncloa, UCM, Madrid, Spain.
(Alonso-Barroso et al., 2017).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2019.101503.
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